Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update

Posted: April 3, 2025 at 2:45 am

BERKELEY HEIGHTS, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today announced fourth quarter financial results and provided a business update.

Read more:
Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update

Related Posts